Carperitide and adiponectin--how are they connected each other to benefit acute decompensated heart failure?
Asanuma
Hiroshi
H
Kitakaze
Masafumi
M
D055372:AMP-Activated Protein Kinases / Q000378:metabolism; D000208:Acute Disease; D052242:Adiponectin / Q000097:blood; D000818:Animals; D009320:Atrial Natriuretic Factor / Q000008:administration & dosage / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D002317:Cardiovascular Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D048909:Diabetes Complications / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D004789:Enzyme Activation; D006333:Heart Failure / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007263:Infusions, Parenteral; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy; D013997:Time Factors; D016896:Treatment Outcome; D015854:Up-Regulation
C499918:ADIPOQ protein, human; D052242:Adiponectin; D015415:Biomarkers; D002317:Cardiovascular Agents; C472955:NPPA protein, human; D009320:Atrial Natriuretic Factor; D055372:AMP-Activated Protein Kinases